Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
367
datasets available to search
ShareScore release 0.9.0
Dataset results
367 results for “Ibrutinib”
Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas
ClinicalTrials.gov study NCT03220022. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ibrutinib in Treating Patients With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT02129062. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Ibrutinib in Combination With Bortezomib and Dexamethasone in Subjects With Relapsed/Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02902965. IPD Sharing: NO. Countries: 6. Publications: 0.
Ibrutinib in Treating Patients With Relapsed or Refractory Transformed Indolent B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT02207062. IPD Sharing: NO. Countries: 1. Publications: 0.
Ibrutinib as Early Therapy in Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT03207555. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ibrutinib in Treating Patients With Advanced Systemic Mastocytosis
ClinicalTrials.gov study NCT02415608. IPD Sharing: NO. Countries: 1. Publications: 0.
A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid Tumors
ClinicalTrials.gov study NCT02403271. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Lymphomas
ClinicalTrials.gov study NCT02401048. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Zilovertamab and Ibrutinib in Patients With Relapsed or Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT05431179. IPD Sharing: UNDECIDED. Countries: 0. Publications: 1.
Trial of Ibrutinib Combined With Nivolumab or Cetuximab to Treat Recurrent/Metastatic HNSCC
ClinicalTrials.gov study NCT03646461. IPD Sharing: NO. Countries: 1. Publications: 0.
Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease
ClinicalTrials.gov study NCT04294641. IPD Sharing: YES. Countries: 1. Publications: 0.
Intravenous BI 836826 in Combination With Ibrutinib in Relapsed/Refractory CLL Patients Who Have Been Pre-treated With at Least One Prior Line of Systemic Therapy, and Who Are Eligible for Treatment W
ClinicalTrials.gov study NCT02759016. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Study of IPH2201 (Monalizumab) With Ibrutinib in Relapsed, Refractory or Previously Untreated CLL
ClinicalTrials.gov study NCT02557516. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Evaluating the Efficacy of Venetoclax Plus Ibrutinib in Participants With T-cell Prolymphocytic Leukemia
ClinicalTrials.gov study NCT03873493. IPD Sharing: YES. Countries: 9. Publications: 0.
A Time-Limited Approach to Treatment With Ibrutinib for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT04694560. IPD Sharing: YES. Countries: 1. Publications: 0.
Study to Assess the Efficacy and Safety of Ublituximab and Umbralisib in Participants With Chronic Lymphocytic Leukemia (CLL) Currently Treated With Ibrutinib, Acalabrutinib or Venetoclax
ClinicalTrials.gov study NCT04016805. IPD Sharing: YES. Countries: 1. Publications: 0.
Venetoclax and Ibrutinib in Patients With Relapsed/Refractory CLL or SLL
ClinicalTrials.gov study NCT03045328. IPD Sharing: NO. Countries: 1. Publications: 0.
Ibrutinib Post Stem Cell Transplantation (SCT) in Double-Hit B-Cell Lymphoma
ClinicalTrials.gov study NCT02272686. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Abexinostat and Ibrutinib in Diffuse Large B-cell Lymphoma and Mantle Cell Lymphoma
ClinicalTrials.gov study NCT03939182. IPD Sharing: YES. Countries: 1. Publications: 0.
Study to Assess Effect of Oral Venetoclax Tablet in Combination With Oral Ibrutinib Capsule on Best Overall Response of Complete Response in Adult Japanese Participants With Relapsed/Refractory Mantle
ClinicalTrials.gov study NCT04477486. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.